MARKET

ORMP

ORMP

Oramed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.100
-0.060
-1.90%
Closed 16:00 09/20 EDT
OPEN
3.150
PREV CLOSE
3.160
HIGH
3.280
LOW
3.070
VOLUME
64.47K
TURNOVER
--
52 WEEK HIGH
4.990
52 WEEK LOW
2.780
MARKET CAP
53.89M
P/E (TTM)
-3.5587
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ORMP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ORMP News

  • We Think Oramed Pharmaceuticals (NASDAQ:ORMP) Needs To Drive Business Growth Carefully
  • Simply Wall St..1d ago
  • Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference
  • PR Newswire.4d ago
  • Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801
  • PR Newswire.5d ago
  • Oramed nearing finish line in mid-stage study of oral insulin
  • Seeking Alpha - Article.5d ago

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About ORMP

Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed’s flagship product, an orally ingestible insulin capsule in phase II clinical trials, is focused on the treatment of diabetes. The Company is developing orally ingestible protein oral delivery (POD) technology for the delivery of drugs presently administered by way of injection. Oramed’s delivery platform protects protein sand enhances their absorption, allowing them to reach the blood stream through the portal vein. The Company’s products include ORMD-0801, Oral insulin capsule; ORMD 0901, Oral Exenatide capsule; and combination therapy of ORMD 0801 + ORMD 0901. ORMD-0801 is under phase II A clinical trials. ORMD-0901 is under preclinical/Investigational New Drug (IND) stage under phase I B.
More

Webull offers Oramed Pharmaceuticals, Inc. (ORMP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.